Pledges and pitfalls: Canada’s legislation on compulsory licensing of pharmaceuticals for export – International Journal of Intellectual Property Management, Vol. 1, Nos. 1/2, 2006

In May 2004, at the urging of civil society advocates, Canada became the first country to enact detailed legislation implementing the August 2003 decision of the World Trade Organization allowing compulsory licensing of pharmaceutical patents in a WTO Member for the purpose of exporting lower-cost generic products to countries lacking sufficient capacity to manufacture their … Read more

Letter of support from NDP Leader Jack Layton re: Global Treatment Access Group

“Thank you for writing me in support of the Make Poverty History campaign’s work at the 16th International AIDS Conference in Toronto. Clearly, Prime Minister Stephen Harper’s absence speaks volumes as to where he places the HIV/AIDS crisis among his priorities. In contrast, NDP Caucus members Bill Siksay, Libby Davies, Olivia Chow, Alexa McDonough, and … Read more

Will it Deliver? WTO rules and Canada’s law on compulsory licensing – The continuing challenge of scaling up treatment access – Event at XVI International AIDS Conference

At this session, Brigitte Zirger (Health Canada), Prof. David H. Mwakyusa (Minister for Health and Social Welfare – Tanzania), Bruce Clark (Apotex), Anil Soni (Clinton Foundation), Rachel Kiddell-Monroe (Médecins Sans Frontières) and Richard Elliott (Canadian HIV/AIDS Legal Network) will present their perspectives on their experience with the Canadian law and the 2003 WTO decision, and … Read more